You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Board of Directors of Modus Therapeutics Holding has resolved to carry out a new issue of up to 20,125,060 shares with pre-emptive rights for the company's shareholders, as well as a directed issue of 10,156,569 shares through the offsetting of loans from Karolinska Development AB amounting to aAlready a…
SmartCella Holding has announced the raising to further advance and accelerate the development of core technologies in the company’s three business units, Procella Therapeutics, Smartwise and SvedMed Solutions. The financing, led by advisor SEB, brings together a renowned group of investors witAlready a subscriber Login You have read all your…
Zealand Pharma has given formal notice to Nasdaq of the company’s intention to voluntarily remove its American Depositary Shares (ADSs) from listing on the New York-based Nasdaq Global Select Market. One ADS currently represents one ordinary share in Zealand Pharma, and today the company’s ADAlready a subscriber Login You have…
Ilya Pharma has closed a 8.5 million EUR funding round where the EIC Fund participated and was joined by an international consortium of family offices and private investors. “I believe Ilya is at the forefront of science by developing what can be the next advancement in biologics, tissue regeneAlready a…
